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Abstract  
Post-weaning diarrhea (PWD) is one of the most serious threats for the swine industry 
worldwide. It is commonly associated with the proliferation of enterotoxigenic Escherichia coli 
(ETEC) in the pig intestine. Colistin, a cationic antibiotic, is widely used in swine for the oral 
treatment of intestinal infections caused by E. coli, and particularly of PWD. However, despite 
the effectiveness of this antibiotic in the treatment of this disease, several studies have reported 
high rates of colistin resistant E. coli in swine. Furthermore, this antibiotic is considered of very 
high importance in humans, being used for the treatment of infections due to multidrug-resistant 
(MDR) Gram-negative bacteria (GNB). Moreover, the recent discovery of the mcr-1 gene 
encoding for colistin resistance in Enterobacteriaceae on a conjugative stable plasmid has raised 
great concern about the possible loss of colistin effectiveness for the treatment of MDR-GNB in 
humans. Consequently, it has been proposed that the use of colistin in animal production should 
be considered as a last resort treatment only. Thus, to overcome the economic losses, which 
would result from the restriction of use of colistin, especially for prophylactic purposes in PWD 
control, we believe that an understanding of the factors contributing to the development of this 
disease and the putting in place of practical alternative strategies for the control of PWD in swine 
is crucial. Such alternatives should improve animal gut health and reduce economic losses in pigs 
without promoting bacterial resistance. The present review begins with an overview of risk 
factors of PWD and an update of colistin use in PWD control worldwide in terms of quantities 
and microbiological outcomes. Subsequently, alternative strategies to the use of colistin for the 
control of this disease are described and discussed. Finally, a practical approach for the control of 
PWD in its various phases is proposed. 
Keywords: Post-weaning diarrhea, pigs, E. coli, colistin, resistance, alternatives.  
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I. Background 
Post-weaning diarrhea (PWD) due to Escherichia coli is an economically important disease in pig 
production worldwide, affecting pigs during the first two weeks after weaning and characterized 
by sudden death or diarrhea, dehydration, and growth retardation in surviving piglets [1, 2]. 
Furthermore, many stress factors associated with the weaning period, such as removal from the 
sow, dietary changes, adapting to a new environment, mixing of pigs from different farms and 
histological changes in the small intestine, may negatively affect the response of immune system 
and lead to an intestinal gut dysfunction in pigs [3-5]. Post-weaning diarrhea is usually associated 
with proliferation of enterotoxigenic E. coli (ETEC) [2, 6]. This pathotype is characterized by the 
production of enterotoxins and adhesins, both essential for disease development [7], the 
predominant adhesins in PWD being F4 and F18 [6, 8]. Small intestinal adhesion and subsequent 
colonization by ETEC in pigs is mediated by F4 or F18 specific receptors, the existence and 
function of these receptors being crucial to determine the susceptibility of pigs to ETEC 
infections [7]. The predominant serogroup of ETEC associated with PWD in pigs worldwide is 
O149, commonly in the combination O149: LT: STa: STb: EAST1: F4ac [2]. Colistin, a 
polymyxin antibiotic produced by Paenibacillus polymyxa var colistinus [9], is widely used for 
the control of PWD in pigs [10]. However, in humans this antibiotic is now considered as the last 
therapeutic option for the treatment of infections caused by multidrug-resistant Gram-negative 
bacteria (MDR-GNB) such as Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella 
pneumoniae and Enterobacter species [11, 12].  
On the other hand, in the last several years, studies have reported the isolation of colistin-resistant 
E. coli from pigs [13, 14], the proportion reaching 35% in some countries [15]. Until recently, 
resistance to colistin had only been associated with non-transferable genome mediated mutation. 
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However, in 2015, a stable plasmid-mediated gene, mcr-1, encoding a phosphoethanolamine 
transferase conferring resistance to colistin was identified in certain GNB, such as	E. coli and 
Salmonella, isolated from various origins including farm animals, raw meat and humans, in 
several countries [16-18]. The discovery of a mechanism for horizontal transfer of colistin 
resistance, and hence the potential for interspecies transfers, gave rise to a strong reaction in the 
scientific community regarding the potential reduction of colistin effectiveness in human 
medicine [19]. Food producing animals, and in particular pigs, have been singled out as the most 
potential reservoirs for spread and amplification of colistin resistance [19]. Thus, scientists and 
regulatory agencies such as the European Medicine Agency (EMA) have recommended reducing 
the use of colistin in animal production and to restrict its use to the treatment of sick animals as a 
last resort option [20]. In addition, several studies have reported coexistence of the mcr-1 gene 
with genes encoding the production of Extended-Spectrum β-Lactamase (ESBL) and 
carbapenemase enzymes [21-23]. This constitutes an additional degree of concern about the risk 
of spread of resistance against antimicrobials of very high importance in human medicine. 
Furthermore, a high prevalence of ESBL-positive E. coli isolated from PWD piglets has been 
reported [24]. Taken together, these findings underline the need to better understand PWD risk 
factors and to find alternatives to antimicrobials and particularly to colistin in pigs for the control 
of PWD in order to manage antimicrobial resistance and maintain at the same time livestock 
productivity. Hence, the aim of the present review was to provide an overview of risk factors of 
PWD as well as an update of information on the extent of colistin use in PWD control worldwide 
in terms of quantities and microbiological outcomes. In addition, alternative strategies to the use 
of colistin for the control of this disease are described and discussed. Finally, a practical approach 
is proposed for the control of the PWD in its various phases. 
The prevalence of colistin resistance in pigs and the possible link between colistin 
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pharmacokinetic/pharmacodynamic (PK/PD) and emergence of resistance in Enterobacteriaceae 
in swine, as well as the aspects that should be considered to ensure judicious use of colistin in 
swine production, have been investigated in our last two reviews [18, 25]. 
II. Search strategy and selection criteria 
Articles published in peer-reviewed journals were searched in the international online databases 
PubMed, Web of Science, and Scopus. The studies were selected based on language (English or 
French) and accessibility to the full manuscript version. Literature was retrieved through an 
electronic search, starting from 1980 to the present. Relevant scientific papers were identified 
using the keyword combinations (piglet OR swine OR pig OR weaned OR sows AND (post-
weaning diarrhea), (post-weaning), (E. coli), (colistin), (colistin resistance), (colistin use), 
(colistin indications), AND (pig OR swine OR weaned pigs OR antibiotics in pigs OR colistin in 
pigs OR E. coli in pigs OR post-weaning diarrhea OR weanling diet in pigs AND (feed 
strategies) OR (alternatives measures) OR (alternatives to antibiotics) OR (preventive strategies) 
OR (additives). All searches were performed from September to November 2016. In total, 389 
nonduplicate articles were found. After applying the inclusion and exclusion criteria, 271 
citations were considered potentially eligible for inclusion in this review.  
III. Risk factors for post-weaning diarrhea in pigs  
Post-weaning diarrhea is an economically important enteric disease in pigs due to financial losses 
[1]. This disease occurs most frequently within the two weeks after weaning and is characterized 
by a profuse diarrhea, dehydration, significant mortality and loss of body weight of surviving 
pigs [2]. Mortality associated with this disease may reach 20% -30% over a 1- to 2-month time 
span among infected weaned pigs during acute outbreaks of PWD [1]. 
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PWD is a multifactorial disease where the exact cause has not yet been identified [26] (Fig. 1). 
The occurrence of PWD in pigs involves interactions between the sow, piglet, environment, 
ETEC bacteria and livestock management [27].  
1. Predisposing factors 
Post-weaning diarrhea is usually associated with the proliferation of one or more strains of β-
hemolytic ETEC in the small intestine of pigs, in particular those that express fimbrial adhesins 
F4 (K88) or F18 [2]. Thus, small intestinal epithelial cell adhesion and subsequent colonization 
by ETEC is mediated by F4- or F18-specific receptors (F4R or F18R), the existence and function 
of which are crucial in determining the susceptibility of pigs to ETEC infection [2, 7]. The 
genetic predisposition of the pig is primordial for the development of PWD [28].  
In addition, conditions related to pregnancy and parturition of the sow such as litter size, parity, 
and postpartum dysgalactia syndrome are significant in the predisposition of piglets to microbial 
infection [27, 29]. The sow placenta is not permeable to maternal immunoglobulin transport and 
therefore newborn piglets acquire maternal immunoglobulin from colostrum during the first 24 h 
to 48 h of life [5]. It was reported that weaning age and preweaning health play a key role in the 
onset of PWD [30]. Moreover, the post-weaning period is a critical phase in the pig's life when 
the intestinal immune system is immature, and	 the sow milk removal, and consequent 
discontinuation of nutritive intake of the IgA present in this milk, contributes to increase 
susceptibility of pigs to microbial infections [31]. Indeed, unlike other food animals, the sow’s 
milk is particularly rich in IgA compared to colostrum [32]. Studies investigating the profitability 
of weaning pigs at an early age, before 21 days, have further encouraged moving away from this 
practice to weaning pigs no earlier than 26 days of age to reduce the occurrence of PWD [30, 33]. 
In the European Union (EU), many pig producers wean piglets at 21 days of age. However 
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welfare legislation encourages weaning no earlier than 28 days of age in the absence of cleaned 
housing sections to ensure that healthy pigs are transferred into nursery accommodation [34]. 
Moreover, studies suggest that increasing weaning age reduces stress associated with this period 
and allows pigs to have a more mature gastrointestinal tract and become increasingly familiar 
with solid feed during lactation with an improvement in growth performance and in immune 
response [34, 35]. 
Feed intake is usually reduced initially after weaning and the pig may develop anorexia of 
variable duration and extent between farms, depending on livestock management and the nature 
of the feed [36]. Madec and collaborators reported that the low feed intake over the first week 
after weaning is strongly correlated with the risk of disease occurrence over the post-weaning 
period [30]. Underfeeding during weaning reduces growth performance of pigs, and contributes 
to intestinal inflammation and adversely affects villous height and crypt depth [3]. This 
morphological disruption of the intestinal mucosa promotes the creation of an ideal environment 
for the multiplication of bacteria such as E. coli and allows toxins and bacteria to cross the 
epithelium as a result of this inflammation [37] (Fig. 2).  
2. Contributing factors 
Housing factors, population density, parity segregated production and the feeding regimen after 
weaning play a role in the development of PWD [38]. 
It is beyond the scope of this review to discuss in detail all the ideal conditions for pig housing 
during the post-weaning period, but to highlight the most important, as reviewed by Le Dividich 
and Herpin [39], it is essential to provide the correct environmental temperature, 26–28°C, to 
maintain pigs in their thermo-neutral zone. Chilling reduces intestinal peristaltic activity and 
consequently increases bacterial colonization, and low temperatures in weaner facilities appears 
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to be responsible for a more severe course of PWD [40]. Also, it has been shown that automatic 
temperature control in the weaners housing reduces considerably the prevalence of PWD [38]. 
Wathes and Whittemore reviewed several recommendations to prevent pig diseases by 
appropriate housing and environmental management [41]. These approaches involve avoiding 
drafts while removing moisture and gases using adequate ventilation. Most often, flat decks are 
used instead of soiled bedding for weaned piglets; however it was reported that this practice is 
accompanied by more tail and belly lesions among pigs [42]. Moreover, the removal of manure 
and soiled bedding on a regular basis is also important to reduce the microbial load on farms.	 
A contradiction was found in the scientific literature concerning the impact of herd size on the 
prevalence of PWD in pigs. Indeed, Laine and collaborators reported that in Finland, the increase 
in pig’s herd size was associated with a higher risk of PWD in pigs [38]. While, in Canada, 
Amezuca and collaborators reported that PWD occurred on a variety of farm types and sizes [43]. 
However, a link between stocking density and PWD was described in pig’s farms in some 
countries [30, 44]. Mixing piglets from different farms is a common practice in pig husbandry, 
particularly at weaning. This mixing can result in fighting as the pigs strive to establish 
dominance relationships, with most aggressive interactions being typically shown during the first 
few hours after grouping [45]. It has been reported that the hierarchical behaviour among pigs 
leads to very significant differences in food and water consumption on farms [46]. Production 
based on segregated sow parities was proposed as a solution to reduce the impact of the social 
hierarchy. This system of grouping according to the sow’s farrowing rank reduces disease 
challenge by reducing variation in the immune status of the piglets [47]. 
It was shown that the prevalence of PWD was higher on farms that fed weaned piglets only twice 
a day with a restricted amount of feed than on farms that provided more than two meals per day 
with or without feed restriction [38]. In addition, Amezuca and collaborators reported that the 
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occurrence of PWD was greater with pelleted feed and inadequate feeder space per piglet in the 
pen [43]. 
A previously mentioned, PWD is a complex disease that may result from interaction between 
several infectious agents. However, most epidemiological studies have focussed on monitoring 
the effect of only one pathogen in the occurrence of this disease, and there is inadequate 
information concerning other relevant enteric pathogens such as viruses and parasites. Some 
investigations of mixed infections in PWD showed that rotavirus was considered to be an 
important enteric pathogen in weaned piglets with a prevalence of 77.5%, followed by E. coli, 
coccidia, sapovirus and Cryptosporidium parvum with prevalence of 55%, 10%, 2.5% and 2.5% 
respectively [48]. In addition, infection by the porcine reproductive and respiratory syndrome 
virus (PRRSv) results in an impairment of the immune response of piglets, permitting ETEC to 
cause a septicemia leading to death [49]. However, these data were reported more than 10 years 
ago and are unlikely to reflect the current epidemiologic situation.  
3. Determining factors 
ETEC is the most common cause of PWD in pigs. This pathotype is characterized by the 
production of enterotoxins and adhesins, both essential for disease development. Enterotoxins 
produced by ETEC may be heat stable (STa, STb, or enteroaggregative E. coli heat stable 
enterotoxin 1 [EAST1]) or heat labile (LT) [2]. Enterotoxin genes are on plasmids of ETEC 
bacteria and act on the intestinal epithelium of pigs [7].  
In pigs, the most frequently found fimbrial adhesins of ETEC are K88 (F4), K99 (F5), 987P (F6), 
F41, and F18 [40]. F4-positive and F18 ETEC (ETEC: F4 and ETEC: F18) strains represent the 
major cause of PWD in pigs. F4 are flexible fimbriae that occur as the F4ab, F4ac, or F4ad 
variant, the F4ac variant being by far the most important type encountered in PWD [50]. The F4 
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fimbriae mediate bacterial attachment to F4 receptors (F4R), present on the small intestinal brush 
borders of villous enterocytes allowing ETEC to survive and persist in the small intestine and 
cause diarrhea [51]. Thus, attachment of ETEC to the pig intestinal mucosa is a crucial step in the 
pathogenesis and the initiation of PWD. Two antigenic variants of F18 fimbriae exist: F18ab 
(F107) and F18ac (2134P and 8813). F18ac is commonly associated with ETEC causing PWD, 
whereas F18ab is often involved in oedema disease [52]. No cross protection between F18ab and 
F18ac was observed on vaccination against F18 variants [53]. A non-fimbrial adhesin identified 
as AIDA (adhesin involved in diffuse adherence) has been observed to be associated with ETEC 
strains recovered from pigs with PWD [54]. In this study, 50.0% of isolates were ETEC-aidA+. 
Moreover, it has been demonstrated that the expression of AIDA by a diarrheagenic E. coli strain 
(AIDA-I+, STb+) was essential for pig’s intestinal colonization and for in vitro bacterial 
autoaggregation and biofilm formation [55]. 
Porcine pathogenic E. coli involved in PWD typically belong to serogroups O8, O138, O139, 
O141, O147, O157 and O149, the latter being the predominant serogroup in most countries [56, 
57]. The most implicated virotype in PWD is ETEC: LT: STb: F4 [6]. However, O serogroup and 
virulence gene patterns vary from region to region and over time [2]. 
Pathogenesis of porcine enteric colibacillosis has been reviewed extensively elsewhere [7, 40, 
57]. Indeed, piglets ingest ETEC found in their environment, especially derived from mammary 
glands of their mother and from the farrowing room or from the pen environment on arrival in the 
nursery (Fig. 2). These ETEC originate from the gut of piglets with ETEC diarrhea, or subclinical 
carrier animals at the farm [57]. ETEC bacteria adhere to pig’s small intestinal epithelium, causes 
an increase of water and electrolytes secretion into the intestinal lumen generated by the release 
of enterotoxins, and alter the functions of enterocytes by increasing secretion and reducing 
absorption [7]. Excessive secretion of electrolytes and water leads to dehydration, metabolic 
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acidosis, osmotic diarrhea and possible death [28, 58-60] (Fig.  2). It has been widely reported in 
the scientific literature that ETEC challenge in pigs was not associated with significant 
macroscopic lesions or morphological changes in the intestinal mucosa resulting from the toxic 
activity of ETEC enterotoxins [57, 61, 62]. However, other studies have reported that the 
necropsy of challenged pigs with ETEC or naturally infected animals, has revealed several 
lesions such as; dehydration, dilation of the stomach and the small intestines, gastric infarcts in 
the mucosa of the stomach, and congestion of the mucosa of both the small intestine and the 
colon [57, 63]. Furthermore, ETEC infections in pigs may also result in a shock syndrome with 
hemorrhagic gastroenteritis, congestion, renal hemorrhage, and thrombi in the mucosa of the 
stomach and small intestine [64-66]. Moreover, intestinal ETEC infections in pigs might 
be associated with secondary septicemia [66] and inactivation of the hemolysin structural gene 
(hlyA) of an ETEC: F4 challenge strain did not decrease the incidence of this septicemia in orally 
challenged gnotobiotic piglets [66]. Thus, macroscopic lesions of shock syndrome and septicemia 
related to ETEC infection in the post weaning period in pigs are probably the consequence of the 
rapid release of bacterial LPS from the pig’s intestine into the systemic circulation [57]. On the 
other hand, microscopically, ETEC challenge in pigs has been associated with a greater villous 
atrophy and a large crypt depth reduction in all segments of the intestine of challenged animals 
[67]. 
ETEC isolates from pig farms with PWD may show a high frequency of resistance to multiple 
antimicrobials [1, 68]. Nevertheless, there is no indication that drug resistance enhances the 
virulence of ETEC, although virulence genes are sometimes associated with drug resistance 
genes [56]. 
Porcine attaching and effacing E. coli (AEEC) induce intestinal lesions similar to those produced 
by enteropathogenic E. coli (EPEC) in humans, and this pathotype is found in pigs with PWD 
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[40]. These E. coli carry the eae gene encoding a 94 kDa outer membrane protein (intimin) which 
is responsible for intimate attachment to epithelial cells. However, the pathogenic significance of 
porcine EAE positive isolates in weaned pigs is still unknown [2]. Furthermore, identification of 
porcine EPEC is difficult and many veterinary diagnostic laboratories do not routinely screen for 
this pathotype of E. coli, isolates of which do not usually possess any of virulence factors of 
classic PWD or oedema strains [40]. 
IV. Extent of colistin use in weaned pigs worldwide  
The global demand for colistin in agriculture is expected to reach 16 500 tons by the year 2021, 
this being one of the least expensive classes of antimicrobials available in veterinary medicine in 
some countries [17]. Thus, the pricing structure makes colistin particularly attractive for use in 
pig production. Since the inception of its clinical use in 1960, colistin has been used in pig 
production in many countries for the treatment and prevention of digestive disorders caused by 
Enterobacteriaceae, and even sometimes for growth promotion over long periods, to improve  
growth rate and feed conversion efficiency in pigs [18, 69, 70]. In certain countries such as 
Canada, where colistin has not been approved for use in pigs, a rapid increase in resistance of 
ETEC to a wide range of antimicrobials has prompted the use of colistin in weaned pigs under the 
veterinarian's responsibility [71]. However, current data on the total quantities of colistin used in 
pigs worldwide have been difficult to obtain accurately [70]. Some data, for example in 
Denmark, indicate that the use of colistin for the treatment of sows increased between 2002 and 
2008 [72]. Of the two forms of colistin commercially available, colistin sulfate (CS) and colistin 
methanesulphonate sodium (CMS), and only CS is approved in pig production in some countries 
[18]. Usually it is administered orally in the drinking water at the dose of 50, 000 IU/kg body 
weight every 12 h for 3 or 5 days [25]. Colistin is mostly used in monotherapy in pigs, although it 
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may be combined with other antimicrobials, such as amoxicillin, for the treatment of PWD [25, 
73].  
1. Colistin use in post weaning diarrhea on farms  
Due to its activity directed against GNB, colistin is widely used for the control of PWD in pigs 
[10, 74]. Two surveys conducted in pig farms in Belgium, in 2006 [73], and 2012 [74] confirmed 
that colistin was the most frequently used antimicrobial for the control of PWD, being mostly 
used prophylactically. However, colistin was underdosed in 90% and 53% of the cases, in the 
first and the second survey respectively. In Germany, it was reported that intestinal diseases in 
weaners were commonly treated with colistin, pigs being treated 9.7 days (median) per 100 days 
with this antibiotic, although tetracycline and tylosin were also used in approximately equal 
amounts [75]. In a study in France, it was reported that 90% of pig farms used colistin during the 
post-weaning period [10]. In Vietnam, a survey conducted on pig farms representing three 
different animal production systems (farm household, semi-industrial and industrial) showed that 
colistin was the most commonly used antimicrobial for prevention and therapy of gastrointestinal 
disorders in pigs [76].  
It has been reported that China is the country with the greatest use of colistin in pigs worldwide 
[17], although we did not find any reports in the literature on surveys of colistin use in this 
country in the post-weaning period. Overall, colistin is widely used in the management of the 
PWD, with a lot of differences between countries in terms of quantities used and modality of 
administration [18]. 
2. Microbiological and clinical outcomes of colistin use in controlled conditions 
Most of the recent studies conducted in pigs have used CS in experimental conditions for the 
control of diarrhea in the post-weaning period (Table 1). Several of these studies were performed 
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to examine the effectiveness of alternative substances to colistin in the treatment of PWD [77, 
78]. 
It is often difficult to compare results between studies, because of the variability in the dose of 
CS used, treatment duration, and the experimental design of the study. In Table 1, we have 
summarized the main results reported in the literature concerning fecal E. coli shedding and pig 
performance following oral CS treatment. Several studies have also followed histological (i.e. 
intestinal mucosa morphology) and biochemical (e.g. d-lactate, nitric oxide, xylose, etc.) 
parameters subsequent to CS use in the post- weaning period in pigs [78, 79]. In order to evaluate 
the effect of colistin on fecal E. coli shedding, bacterial quantification was performed in most 
studies using culture methods [28, 77], whereas other studies used real-time PCR [79, 80]. 
Furthermore, the oral use of a high dose of colistin in healthy piglets was not associated with a 
major perturbation in the pig gut microbiota as demonstrated by a high-throughput sequencing 
method [80]. 
Although colistin has been used in some studies to promote animal growth, data were not 
conclusive to support the effectiveness of this practice [81]. In this study, no difference was 
observed between the CS treated and the control group in terms of Average Daily Gain per day 
(ADG/d) [81]. Also, the economic benefits of antimicrobial growth promotion in modern farms 
have been questioned [82], the benefit of this use being associated with poor hygiene on farms. 
V. Alternative strategies to colistin for post-weaning diarrhea control  
Reduced colistin usage in livestock and particularly in swine is highly promoted worldwide and 
is required in Europe as a public health measure to reduce colistin resistance spread, and to 
prevent the loss of polymyxins effectiveness in human medicine [25]. Furthermore, concurrent 
treatment with colistin in piglets was associated with the isolation of resistant bacteria from the 
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earliest days of treatment [28]. Almost all studies conducted on isolates from pigs worldwide to 
screen mcr-1 gene presence in enterobacterial species reported that colistin resistant isolates 
harboring this gene also showed resistance to one or several classes of antimicrobials 
conventionally used in swine such as: Aminoglycoside, Sulphonamide, Trimethoprim, 
Tetracycline, Quinolone, Lincosamide, β-lactam, and third generation cephalosporin [83-86]. 
However, to ensure swine welfare, productivity and reduced mortality associated with PWD, 
alternatives to colistin and other antimicrobials, especially those of critical importance for human 
health, are essential in pigs. There is a major debate over the terminology ‘alternative to 
antibiotics’ because we do not propose substances with antibacterial activity but rather substances 
that act on bacteria indirectly, either by stimulating the host immune system, by the release of 
substances that have antibacterial activity or by improving the host gut health and consequently 
growth performance [87]. Thus, we will use the terminology «strategies» or «measures» to 
describe alternatives to antimicrobials. Due to the multifactorial etiology of PWD, finding case-
specific preventive measures against this disease is a challenge for both researchers and 
veterinarians. Here we give an overview of these preventive strategies, focusing on the most 
practical and promising ones for the control of PWD in pigs.  
1. Preventive measures  
In the literature, many alternatives to antimicrobial usage in food-producing animals have been 
reported and discussed [87-90]. The most promising way to mitigate the development of colistin 
resistance is to reduce the use of antimicrobials at the farm level (Table 2). There are documented 
relationships between housing conditions and incidence of PWD in pig herds; Madec and 
collaborators claimed that prevention of PWD disorders could be based solely on the control of 
zootechnical conditions [30]. Moreover, stocking density reduction could be considered as a 
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paramount strategy to decrease occurrence of PWD as well as other diseases in pigs [91]. Thus, 
improvement of breeding conditions in pig farms is a crucial measure to reduce the susceptibility 
of animals to microbial infections and consequently to reduce the use of antimicrobials in pig 
production [28]. The management strategies around weaning should focus on measures that avoid 
any kind of stress for pigs. These measures include preventing the spread of infection, providing 
the pigs with good thermal comfort, giving them adapted feed and allowing access to this feed for 
all pigs.  
Considerable research has been performed into developing diets for weaners and there is now a 
range of high quality diets that are readily digested by the early-weaned pig [31]. The main 
purposes of these diets are to achieve high post-weaning feed intakes and minimize duration of 
post-weaning anorexia and consequently growth retardation. It has been reported that the 
presence of some ingredients in the feed for weaners, such as soybeans, seems to favor the 
occurrence of PWD [92]. This could be due to the presence of trypsin inhibitors or antigens 
inducing a localized immune response [2]. Furthermore, it was shown that soya bean meal (SBM) 
reduced duodenal specific activities of most intestinal enzymes and increased crypt depth in pigs 
[93]. Thus, such ingredients should be avoided in feed of early-weaned pigs. In addition, feeds 
with decreased protein content and the addition of organic acid to reduce gastric pH were found 
to decrease E. coli colonization and to minimize PWD prevalence [31].  
The scientific community increasingly recognizes the importance of communication and 
awareness among farmers in relation to antimicrobial resistance, as reflected by the growing 
number of publications in this area in recent years [18, 94]. This suggests that farmers’ 
perceptions, and the factors affecting their behaviour, need to be better understood if effective 
measures associated responsible and prudent use of antimicrobials are to be implemented 
successfully.  
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Moreover, effective diagnostic tools are essential for veterinarians to confirm the bacterial 
etiology of PWD and to determine the antimicrobial susceptibility of the identified bacterial 
strain. The laboratory diagnosis is particularly important in PWD to avoid the inappropriate use 
of antimicrobials. DNA-based molecular detection methods such multiplex PCR based on the 
detection of ETEC virulence genes are rapidly becoming part of the routine laboratory diagnosis 
of PWD, and these genes are used as a biomarkers of ETEC strain [7, 58].  
In several countries, implementation of financial penalties for high antimicrobial users is 
proposed as a method to reduce antimicrobial usage and pig farmers would receive a financial 
bonus when they use alternative methods or when they greatly reduce antimicrobial use on their 
farms [94]. Vaccination seems to be an effective approach to reduce the occurrence of PWD and 
to reduce infection pressure and increase immunity in the pig population [2]. Several studies 
conducted in pigs confirm a reduction of antimicrobial usage after vaccination [95]. In fact, 
vaccination against the porcine proliferative enteropathy caused by Lawsonia intracellularis 
reduced the need for therapeutic oxytetracycline administration in Danish pigs [96]. Live 
attenuated and wild type avirulent E. coli vaccines appear to be promising for the control of 
ETEC infections and live vaccine against ETEC: F4, is now available in Canada and Europe [97]. 
This vaccine is added to the drinking water and recommended for the vaccination of healthy 
weaned pigs of 17 days or more. Clinical studies confirmed that administration of this vaccine 
significantly reduced intestinal colonization by virulent ETEC: F4 and the accumulation of fluid 
in the intestines after an experimental challenge [98]. The immunity in piglets begins 7 days after 
oral vaccination, however, since PWD caused by ETEC: F4 occurs shortly, in the first week, after 
weaning, an immune trough may exist in the first days after weaning during which the pigs are 
not protected [97]. Thus, the time of the administration of this vaccine should be adjusted. In 
addition, clinical trials of vaccination against ETEC: F18 has been carried out in pigs. Genetically 
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susceptible pigs were vaccinated orally on three consecutive days, beginning 10 days before 
weaning with a live F18ac-positive E. coli vaccine [53]. In this study, a significant rise in F18ac-
specific serum IgA and a 3 Log CFU decrease in fecal shedding of the F18ac-positive challenge 
strain was observed compared to the unvaccinated group. However, this vaccine did not induce 
protective immunity against ETEC: F18. On the other hand, it was shown that a minor subunit of 
F18 (FedF) alone or genetically fused to F4 FaeG subunit or conjugated to F4 fimbriae induced 
protective anti-F18 antibodies in pigs [99]. In general, the success of a vaccine against PWD 
depends largely on the identification of the most prevalent ETEC pathotype present in the farm, 
resulting in matching of the appropriate protective antigens with the adhesin produced by the 
ETEC present on the farm, and administering it at the optimal time [7]. For vaccines consisting of 
live F4 or F18ac-positive E. coli, it is often recommended to vaccinate suckling pigs to obtain a 
strong mucosal immunity production, IgA, before weaning. However, our knowledge is very 
limited about the effect of maternal antibodies on the survival of these vaccine strains in the 
intestine of pigs of this age. Also, there is no cross protection against ETEC strains expressing a 
different fimbria or toxin. Recently, plant-based vaccines for protection of pigs against ETEC 
were investigated. A rice-based cholera vaccine expressing the choleratoxin (CT) subunit B 
(CTB) (MucoRice-CTB) was tested in pigs for protection against LT-ETEC infection [100]. 
CTB-based vaccines can target not only F4-type but also F18-type ETECs, and this vaccine also 
induced maternal CTB-specific IgG and IgA in the colostrum and milk of sows after farrowing. 
CTB-specific antibodies were also secreted into the gut lumen of weaned pigs and reduced 
intestinal loop fluid accumulation upon ETEC challenge, indicating a protective effect of this 
vaccine against ETEC diarrhea [100]. However, the cost of these vaccines is very high and, 
unlike open-air farming, the production of transgenic plants for biotherapeutic use is very 
demanding. Moreover, the procedures for manufacturing and processing of plant-based 
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pharmaceuticals are not well defined. Thus, a large-scale production of these vaccines not 
envisaged, at least in the near future. Current progress in the development of subunit vaccines 
against ETEC associated with diarrhea in humans and animals has been reviewed extensively 
elsewhere [97, 101]. However, none of these subunit vaccines has been marketed in swine.  
The selection of animals genetically resistant to ETEC F4 and/or F18 is considered as a radical 
solution to eliminate the PWD in a swine herd. However, progress in this area is very limited or 
even non-existent. Pigs that are resistant to ETEC: F4 and/or F18 do not express intestinal 
receptors for these fimbrial types [2]. The expression of these receptors is genetically determined 
and inherited in a dominant way and the loci controlling F4R and F18R expression are located on 
separate chromosomes. The gene underlying resistance to F4ab/ac ETEC has been assigned to 
porcine chromosome 13, whereas the F4ad ETEC receptor is located on another chromosome that 
was not identified [102]. A PCR-RFLP test has been developed to allow genotyping for F4ab/ac 
ETEC resistance/susceptibility [103]. Three different genotypes were observed and were 
identified as resistant (RR), susceptible heterozygote (SR) and susceptible homozygote (SS). 
However, it cannot be predicted if additional types of adhesive fimbriae or new variants of 
known types will emerge which could bind to yet unidentified receptors and could cause 
outbreaks of diarrhea and mortality in the nursery [2]. It is difficult to understand the reasons 
behind the non-exploration of the genetic breeding for ETEC resistant pigs to reduce economic 
losses associated with PWD and to reduce the use of antimicrobials on farms. It was shown in an 
early study that F4 susceptible piglets tend to have better growth performance then F4 resistant 
ones [104]. Also, heterozygous F4R− piglets are not passively protected from infection by ETEC: 
F4 strains [105]. 
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2. Feed additives  
In pigs, PWD can be controlled using various preventive strategies without using antimicrobials 
(Table 3). Feed supplements such as zinc oxide, organic acids, pre-probiotics, synbiotics, 
dehydrated porcine plasma, antimicrobial peptides, specific egg yolk and bacteriophages [31, 89, 
106-110] have been used in weanling pigs to enhance growth, feed efficiency and to reduce 
PWD. Here we give an overview of these feed strategies, focusing on the most used practices 
showing clinical effectiveness in reducing symptoms of PWD and ETEC attachment to 
enterocytes.  
Zinc oxide: it has been shown that the addition of zinc (Zn) as zinc oxide (ZnO) at the levels of 
2400 to 3000 ppm in pig feed was effective in the reducing of PWD and mortality and in 
improving growth performance in weaned pigs [111, 112]. However, Amezcua and collaborators 
reported an important proportion of farms with PWD occurrence using high levels of ZnO [1]. 
Also, several studies reported an increased proportion of E. coli isolates resistant to tetracycline 
and sulfonamides in pigs fed with high zinc doses [113, 114]. This may explain why 
antimicrobial resistance persists even in the absence of antimicrobial exposure [115, 116]. 
Moreover, the use of high zinc levels in pig feeds has led to heavy metal contamination in the 
soil, raising environmental concerns [115]. Recently, Bouwhuis and collaborators reported that 
organic zinc (zinc methionine (ZnM)) could be used as a substitute for the inorganic zinc (ZnO) 
in the pig diet [117]. In fact, organic zinc can be supplemented in lower doses (up to 500 mg/kg 
feed) compared to ZnO [117]. In this study, the inclusion of ZnM resulted in improved faecal 
scores and the intestinal architecture compared to that observed in pigs supplemented with ZnO.  
Organic acids such as citric, fumaric, lactic, propionic, benzoic and formic acids showed 
beneficial effects in the pig gastrointestinal tract. In fact, the use of organic acids in weaned 
piglets was associated with a reduction of stomach pH [118]. With this effect, organic acids 
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generate a hostile gastric environment for bacterial survival. Moreover, organic acids promote the 
conversion of pepsinogen into pepsin in the stomach of pigs, and promote the activity of this 
enzyme [108]. On the other hand, decreasing the intestinal pH is probably not a primary effect of 
feeding organic acids in pigs. Indeed, Risley and collaborators reported a non significant decrease 
in the pH of the small intestine in 3-week-old weanling pigs fed with a diet supplemented with 
1.5% fumaric or citric acid [119]. Addition of organic acids to weaned pig diets improved growth 
performance and health [31] as well as the local immunity in the jejunum epithelium [120]. It was 
reported that regardless of the organic acids used in the feed, these compounds reduced the 
incidence and severity of diarrhea in pigs, and improved the performance of the treated group 
compared to that of the negative control group [121].  
Prebiotics are selectively fermented components of feed, indigestible by the host animal, that 
modulate the gut microbiota to benefit host health. Resulting effects include the stimulation of 
short-chain fatty acid (SCFA) production and the proliferation of bifidobacteria and lactic acid 
bacteria such as Lactobacillus spp. and Bifidobacterium spp [122, 123]. Common prebiotics 
include inulin and oligosaccharides such as galactooligosaccharides (GOS) and 
fructooligosaccharides (FOS) [124]. Pigs fed with chito-oligosaccharides (COS) showed better 
overall intestinal health (based on villi height), improved performance (measured by body weight 
gain and feed conversion ratio) and higher Lactobacillus counts than those found in control pigs 
or pigs receiving diets supplemented with chlortetracycline [125]. Also, fermented ingredients, 
such as non-starch polysaccharide hydrolysis products of soybean meal (SBM) in weaned pig 
feed, were found to interfere with attachment of ETEC to enterocytes and were beneficial in 
maintaining fluid balance during ETEC infection [126]. It was shown that the prebiotic β-
galactomannan (βGM) inhibited the in vitro adhesion of ETEC on the cell surface of porcine 
intestinal IPI-2I cells, and decreased the mRNA ETEC-induced gene expression of pro-
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inflammatory cytokines such as TNF-α, IL-6, GM-CSF and chemokines on intestinal IPI-2I cells 
[127].  
Probiotics such as	 lactic acid bacteria, Bacillus and yeasts are live microbial feed supplements 
[122]. Probiotic bacteria have also been shown to produce antimicrobial molecules, such as 
bacteriocins, and to inhibit the production of bacterial toxins or the adhesion of pathogens to the 
intestinal mucosa [123]. Several studies demonstrated that pretreatment with certain probiotics, 
such as L. rhamnosus, was effective in reducing diarrhea in experimental ETEC: F4 PWD in 
pigs, possibly via the modulation of the intestinal microbiota, enhancement of intestinal antibody 
defense, and regulation of production of systemic inflammatory cytokine [128]. Recently, Lane 
and collaborators reported that L. acidophilus supplementation (0, 2%) in the weaned pig diet 
resulted in higher Lactobacillus counts and lower E. coli counts, as well as an increase in ADG 
and the average daily feed intake in supplemented pigs compared to the basal diet pigs [129]. A 
Bacillus licheniformis and Bacillus subtilis spore mixture (BLS-mix) was effective in preventing 
loss of intestinal epithelial barrier integrity after a challenge with ETEC: F4 in experimental 
PWD [130]. In addition, it was shown that the feeding of pigs with live yeast Saccharomyces 
cerevisiae enhanced their growth and reduced the duration and the severity of PWD caused by 
ETEC [131]. It has been demonstrated that the administration of a mixture of two probiotics, 
Pediococcus acidilactici and Saccharomyces cerevisiae boulardii, in the feed of challenged 
weaned pigs reduced ETEC: F4 attachment to the ileal mucosa in comparison with the group 
treated with chlortetracycline and tiamulin [103]. 
Synbiotics refers to a combination of probiotic and prebiotic approaches; it is possible that a 
prebiotic that confers gastrointestinal health benefits could selectively increase the population 
and/or activity of probiotics in the gut [132].  Synbiotics can be either complementary or 
synergistic. Complementary synbiotics consist of a probiotic and a prebiotic selected 
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independently to confer benefits to the host. On the other hand, synergistic synbiotics are 
comprised of a prebiotic chosen specifically for the selected probiotic to potentiate its effect in 
the gut [133]. It was shown that the combination of raw potato starch and a probiotic had a 
beneficial effect on pig growth performance and resulted in a reduction of diarrhea and increased 
microbial diversity in the gut of weaned pigs challenged with an ETEC: F4 strain [134]. Also, 
Guerra-Ordaz and collaborators showed that following a challenge of pigs with pathogenic E. 
coli (O149:K91:H10), administration of a prebiotic oligosaccharide, lactulose, in the feed 
resulted in improved weight gain, increased lactobacilli and the proportion of butyric acid in the 
colon, and less inflammation due to a reduction of the pig major acute-phase protein (Pig-MAP) 
in serum [135]. Administration of Lactobacillus plantarum in the feed promoted lactobacilli 
growth, modulated fermentative activity, reduced inflammation, and improved intestinal mucosa 
function and showed a tendency to reduce diarrhea. The application of a synbiotic diet resulted in 
the benefits of both diet regimes, thus being an example of a complementary synbiotic [135].  
Spray dried plasma (SDP) is a protein rich product obtained from the industrial fractionation of 
blood from healthy animals [106]. It was shown that addition of SDP to the feed improved 
growth performance, and protects pigs against ETEC: F4 infection by reducing the intestinal 
expression of inflammatory cytokines such as TNF-α and interleukin-8 and maintaining mucosal 
integrity, and enhancing specific antibody defense [111]. Spray dried plasma (SDPP) of porcine 
origin has been pinpointed as a potential source for the coronavirus in a recent epidemic of 
Porcine Epidemic Diarrhea (PED) [136]. Thus, spray-dried chicken plasma (SDCP) has been 
evaluated as a replacement for SDPP in weaned pigs. Indeed, the effect of SDCP on serum 
biochemistry, intestinal barrier function, immune parameters, and the expression of intestinal 
development–related genes in piglets was similar to SDPP [137]. Nevertheless, a study has 
provided evidence that PED virus is inactivated during the SDPP production process [138]. 
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Antimicrobial peptides (AMPs) are small molecules constituting an important part of the innate 
immune system. They may present antibacterial, antifungal, antiparasitic, and antiviral activities, 
and are increasingly of interest as alternatives to classic antibiotics [88]. AMPs such as 
lactoferrin, cecropin, defensin, plectasin and bacteriocins showed beneficial effects on growth 
performance, nutrient digestibility, small intestinal morphology and gut microbiota in pigs [89]. 
Available data on the effect of AMPs on swine health and especially in the control of PWD have 
been reviewed extensively elsewhere [89, 139]. Antimicrobial lactoferrin peptides are one of the 
most commonly used AMPs in pig feeds. More recently, it was shown in a murine model of 
intestinal inflammation that treatment with porcine lactoferrin-derived peptide LFP-20 was 
effective in the prevention of histological damage, the inflammatory response and the disruption 
of tight junction structure induced by LPS in the intestine [140]. Colicins, a class of bacteriocins 
produced by E. coli and closely related species, have been shown to inhibit the activities of 
ETEC: F4 and F18 strains in vitro and in vivo, and improve the growth performance, reduce the 
incidence of PWD and the expression of the interleukin 1β and tumor necrosis factor beta genes 
in ileal tissues of pigs [141]. On the other hand, resistance to AMPs has been observed in vitro in 
GNB such as E. coli [142]. Thus, the use of AMPs in pig farms needs careful and controlled 
implementation to limit possible resistance development and cocktails of AMPs might be useful 
to mitigate selection for resistance [88]. 
Specific egg yolk antibodies: The chicken egg yolk is a source of large quantities of relatively 
inexpensive IgY antibodies [2]. Several studies reported that specific chicken antibodies provide 
protection against ETEC infections in pigs [111]. Despite the effectiveness of this practice, we 
have not found in the recent literature (last 5 years) any studies evaluating the use of specific egg 
yolk antibodies in PWD control. This is probably the consequence of the non- profitability in pig 
production of this practice, or the lack of protection against ETEC challenge or PWD occurrence, 
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possibly because the antibodies contained in the eggs are not specific against the infected ETEC 
strains present on the farm [143]. 
Bacteriophages are highly species-specific viruses that can infect and kill bacteria. They have 
been widely evaluated in clinical trials to treat bacterial infections in pigs as an alternative to 
antibiotics use [144]. Recently, it was reported that dietary supplementation with bacteriophages 
for the treatment of PWD caused by an ETEC: F4 strain in an experimental model, was effective 
in reducing rectal temperature, faecal consistency score, E. coli adhesion score in the ileum and 
caecum, and villous height: crypt depth (VH: CD) ratio in the duodenum and jejunum [145]. 
However, there are several disadvantages associated with the use of phage therapy in swine. 
Phages have a narrow spectrum of activity directed against a limited number of bacteria and the 
possible development of bacterial resistance against phages has to be considered [144]. To 
overcome the narrow spectrum of activity, some recent studies have reported beneficial effects of 
a bacteriophage cocktail used in the feed for weanling pigs. This combination resulted in 
enhanced growth performance and gut health of pigs, although the combination of phages with 
probiotics did not show any additional effect [109]. Some authors have considered that the 
development of phage-resistant bacteria could be positive for the host [146]. In fact, resistance to 
phages can reduce the fitness of the bacteria and could thereby impair their competitive capacity 
and consequently their ability to colonize the intestinal mucosa of the host [146].  
Others: Several studies have documented a significant improvement of weight gain, and feed 
conversion, as well as the reduction of the incidence, severity and duration of diarrhea in weaned 
pigs fed diets supplemented with substances such as: exogenous enzymes [147], milk products 
[148], clay minerals [149], and medicinal plants [150]. Although many peer-reviewed studies 
discussing these substances are available in the scientific literature, most of the clinical studies 
were performed in experimental conditions. More research is needed to evaluate the potential 
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effectiveness of these substances under field conditions for the control of PWD in pigs.  
3. Results of comparative studies  
Several studies have been carried out in experimental conditions to assess the effectiveness of 
alternatives to colistin for the control of PWD in pigs (Table 4). Here, we give an overview of 
studies published in 2015 or 2016. 
Several recent experimental studies have now shown that some alternatives (Table 4) resulted in 
similar or superior clinical outcomes compared to colistin for improving growth performance and 
intestinal integrity and in reducing of incidence of diarrhea in weaned pigs. In fact, no difference 
was observed in growth performance of weaned pigs supplemented with hop β-acids (120, 240, 
or 360 mg/kg) or colistin (40 mg/kg) during a trial period of 35 days [151]. Moreover, the 
supplementation of weaned pigs with two Macrocephala flavored powder (3000 mg/kg) 
increased significantly villus height in the duodenum and jejunum compared to that observed in 
colistin (300 mg/kg) supplemented pigs [152]. However, these studies (Table 4), were conducted 
in experimental conditions and in most cases in healthy weaned pigs. Thus, further research is 
needed to demonstrate the stability and the efficacy of such alternatives (probiotics, AMPs, 
medicinal plants) in field conditions as well as the safety of these substances in animals and for 
consumers. Also, work is needed to optimize the doses of these substances to incorporate in the 
feed to ensure their effectiveness in PWD control. The financial cost and the ease of 
administration of such alternatives are the other important criteria that should be taken into 
consideration in pig production.  
4. Limits and perspectives  
A long and growing list of compounds have been tested for their ability to replace colistin or 
other antibiotics for the control of PWD in pigs. However, it is difficult to identify a single 
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“ideal” solution for PWD management. Also, as was discussed above, PWD is a multifactorial 
disease and the exact overall etiology has not yet been fully elucidated, making it difficult to 
choose suitable alternatives. Moreover, the most of these alternatives produce inconsistent results 
regarding their effectiveness in field conditions [107]. Oral administration of specific-antibody-
containing egg yolk, or SDP to weaned piglets showed in some cases no protection against ETEC 
strains or PWD outcomes, likely because the contained antibodies were not specific against the 
infecting ETEC strains present on the farm [2]. The composition of plant extracts, organic acids 
and probiotics is complex and knowledge regarding their mechanisms of action is poor, resulting 
in variable results and safety risks [87]. Synergy mechanisms of probiotics and prebiotics are not 
very well known nor well studied [133]. Although AMPs and bacteriophages helped in the 
treatment of PWD, the bacterial resistance risk, the high cost and the narrow antibacterial 
spectrum of these alternatives reduce their practical use on farms [88]. Vaccination is one of the 
most promising strategies for the control of PWD in pigs both in terms of preventive ability and 
cost-effectiveness [97]. The control of production parameters (temperature, ventilation, density, 
sanitation, biosafety, improvement of feed quality) are crucial factors for the control of PWD and 
the reduction of the use of antimicrobials during the post-weaning period [28]. However, the 
improvement of farm conditions and management requires investment and awareness of pig 
farmers. Furthermore, the use of regular diagnostic testing is crucial to ensure an appropriate 
choice of the antimicrobial and to monitor its effectiveness on farms. Thus, efforts to improve 
microbiological laboratory detection methods are of paramount importance to help the 
veterinarian to act rapidly at an early stage of the disease [153]. 
For the management of PWD in different stages of its evolution, we propose a comprehensive 
approach that involves producers, the nutrition industry, veterinarians, the diagnostic laboratory, 
and researchers (Fig. 3). The absence of a well-identified etiology of PWD and of an effective 
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alternative to antimicrobials requires a close collaboration between the different stakeholders to 
reduce antibiotic resistance and economic losses caused by this disease in swine.  
VI. Conclusion  
Despite the progress that has been observed in modern pig farms during the last decade to prevent 
infectious diseases and improve global animal health, PWD remains a problem that causes 
significant economic losses in pig production. Antibiotics have contributed significantly to 
mitigate the economic losses caused by infectious diseases and particularly PWD in swine. 
However, increasing bacterial resistance leading to therapeutic failures on farms as well as the 
greater vigilance of consumers regarding antimicrobial residues, have resulted in more intensive 
research and a large number of clinical trials for the development of alternatives to 
antimicrobials. Thus, several alternatives have been developed, some of which have been 
commercialized for the management of PWD in pigs. However, the effectiveness of these news 
therapies has been variable from one farm to another due to the management of livestock and 
farm conditions. Although some alternatives have show comparable efficacy to antimicrobials or 
colistin in the control of PWD, there is still a considerable gap between these alternatives and 
antibiotics concerning their effectiveness in PWD control. Control of housing conditions and 
vaccination are the most promising strategies for the prevention of PWD in pigs and for reducing 
of the overall use of antimicrobials on farms. However, the establishment and the effectiveness of 
these strategies depend on the involvement of all stakeholders in pig farming. Judicious use of 
antimicrobials in pigs and continued development of alternatives to antimicrobials and colistin 
remains a priority to ensure a long-term sustainable development in pigs. 
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Table 1 Microbiological and clinical outcomes of monotherapy with colistin in pigs 
 
Bacterial 
agents/condition 
Dose per 
day 
Duration 
(days) 
Sample 
type 
Reduction 
in E. coli 
(log cfu/g)* 
Performance 
(ADG, g/d) 
Reference 
E. coli K99 
/Experimental 
PWD 
300 mg/kg 
of diet 
7 -Ileum 
-Cecum 
6.55 
6.63 
 
122b [154] 
E. coli K99 
/Experimental 
PWD 
300 mg/kg 
of diet 
10 -Ileum 
-Cecum 
2.3 
3.2 
128a [77] 
Weaned pigs 
(clinically 
healthy) 
200 mg/kg 
of diet 
7 N/A N/A 229a [155] 
ETEC mixture 
/Experimental 
PWD 
200 mg/kg 
of diet 
21 -Ileum 
-Cecum 
-Colon 
1.54 
1.65 
0.65 
292b [156] 
ETEC mixture 
/Experimental 
PWD 
2.5 mg/ 
animal 
(Oral-
Water) 
21 Fecal 
samples 
3 283b [78] 
Weaned pigs 
(clinically 
healthy) 
40 mg/kg 
of diet 
14 -Ileum 
-Cecum 
-Colon 
N/A 142.2a [81] 
E. coli K88 
/Experimental 
PWD 
4,8 mg/kg 
(Oral-
Water) 
5 Fecal 
samples 
4 214a [28] 
E. coli K88 
/Experimental 
PWD 
9,6  
mg/Kg 
(Oral-
Water) 
5 Fecal 
samples 
4 N/A [28] 
Weaned pigs 2,4 mg/kg 5 Fecal 2††  N/A [80] 
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(clinically 
healthy) 
(Oral-
Water) 
samples 
Weaned pigs 
(clinically 
healthy) 
172,8 
mg/kg of 
diet 
14 Fecal 
samples 
4.5†† N/A [80] 
PWD: Post-Weaning Diarrhea. ADG: Average Daily Weight Gain. N/A: not available. 
*Reduction compared to the control group. ETEC: Enterotoxigenic Escherichia coli. a: Not 
statistically significant compared to the control group. b: Statistically significant compared to the 
control group.†: log (copies/g). ††: log cfu of Enterobacteriaceae /g. 
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Table 2. Preventive strategies to reduce the use of antimicrobials during the post-weaning 
period 
Strategies  Benefits Limitations References 
 
Control of housing 
environment and 
improved 
biosecurity 
-Very effective approach 
-Significantly reduces PWD 
occurrence 
- Reduces the use of 
antimicrobials in farm 
- Sustainable approach 
 
-Significant cost 
-Extreme weather 
conditions in some countries 
-Acceptability of farmers to 
change some management 
techniques  
-Financial support is 
required  
 
[28, 30] 
Diet management 
(reducing the 
amount of soybean) 
-Reduces the severity and 
frequency of PWD and oedema 
disease 
-Reduction of histological 
changes in intestinal crypt and 
villi 
-Growth retardation 
- Increase production 
- Considerable controversy 
between studies 
[31] 
Communicative 
advisory tools for 
pig farmers  
-Improving breeding 
management  
-Farmers feel concerned by the 
problem of antibiotic resistance 
-Raised awareness and 
responsibility 
 
-Requires a lot of field work 
- Farmers worried mostly  
about infectious diseases 
and financial issues 
-Financial bonus is required 
[94] 
Laboratory 
diagnosis to confirm 
etiology of PWD 
-Avoid the use of 
antimicrobials to treat viral 
diarrhea 
- Allows an appropriate choice 
for antibiotics 
- Significant cost 
- Lack of rapid diagnostic 
techniques 
[95] 
Policy measures -Reduce the sale and the use of 
antimicrobials on farm 
-Reduce self-medication 
-Requires penalties 
-Financial bonus is required 
[94] 
Immunoprophylaxis: 
Live attenuated and 
live wild type 
avirulent E. coli 
-Specific protection against 
ETEC: F4 or F18 
-Easy to administer on farms 
(drinking water) 
-Reduces antimicrobial use in 
the PW period  
-Interference with the 
lactogenic immunity of 
piglets 
-Absence of cross-
protection between F18ab 
strains 
[97] 
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-Marketed in swine - Limited availability in 
some countries 
Immunoprophylaxis: 
Subunit vaccines 
(Purified F4 
fimbriae) 
- A powerful oral immunogen 
- Leads to a specific mucosal 
immune response 
-Leads to a significant 
reduction in fecal excretion of 
ETEC: F4  
-The proposed 
immunization procedure 
required large quantities of 
F4 
- Antigen degraded by the 
pH of the stomach and by  
digestive enzymes 
-Usually required mucosal 
adjuvant such as Cholera 
toxin 
[8] 
Breeding of resistant 
pigs 
-Very effective approach  
-Greatly reduces the total 
amount of antimicrobials used 
on farms 
-Reduces the selection pressure 
-Expensive process 
-Lack of techniques for a 
large-scale selection 
- Development of other 
adherence mechanisms 
 
[2] 
PWD: Post weaning diarrhea	
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Table 3. Benefits and limitations of the major alternative feed strategies for the control of 
PWD in pigs 
Strategies  Benefits Limitations References 
 
Zinc oxide -Inhibition of 
bacterial adhesion to 
the intestinal mucosa 
-Stimulated growth 
rate 
- Maintained 
intestinal mucosal 
integrity 
-Modulated immune 
functions 
 
-High levels increased 
PWD 
- Soil heavy metal 
contamination 
-Bacterial resistance 
-Co-resistance 
[112, 115] 
Organic acids -Decreased pH in the 
stomach 
-Improved growth 
performance 
- Reduced PWD 
- Exact modes of 
action still unknown 
-Anti microbial 
activities is different 
between acids 
[108] 
Prebiotics, Probiotics 
and Synbiotics 
-Improved intestinal 
health 
-Improved growth 
performance 
- Reduced ETEC: F4 
attachment to the ileal 
mucosa 
-Reduced diarrhea 
- Sometimes 
contradictory studies 
on their effectiveness 
-Lack of information 
on the potential 
synergism between 
pre- and probiotics 
[127, 130] 
Spray dried plasma 
(SDP)  
-Improved growth 
performance 
-Reduced incidence 
and severity of 
diarrhea 
- Reduced the markers 
of intestinal 
inflammation 
-Maintained mucosal 
integrity 
- High cost 
- Required rigorous 
control during the 
preparation process 
- Potential source of 
pathogens? 
[111] 
Antimicrobial 
peptides (AMPs) 
-Improved growth 
performance 
-Decreased diarrhea 
-Reduced the markers 
of intestinal 
-The 
pharmacokinetics in 
vivo is unknown 
-Bacterial resistance 
 
[89, 139] 
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inflammation 
-Enhance immune 
function 
-Cocktails of AMPs 
might be used to 
mitigate selection for 
resistance 
 
Specific egg yolk 
antibodies 
-Improved growth 
performance 
-Decreased diarrhea 
-Maintained intestinal 
mucosal integrity 
-High cost 
-Antibodies are 
sometime not specific 
against the infecting 
ETEC strains on 
farms 
[111] 
Bacteriophages -Reduced E. coli 
mucosal adhesion 
-Maintained intestinal 
mucosal integrity 
-Decreased diarrhea 
 
-Narrow spectrum of 
activity 
-Development of 
bacterial resistance 
-A combination of 
phages is needed 
[144] 
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Table 4. Effects of colistin compared to alternative measures for control of PWD in pigs. 
Trials  ADG 
(g/day) 
Ileum Villus 
height (µm)  
Ileum 
Crypt 
depth (µm) 
E. coli (log 
10 CFU/g) 
Diarrhea  References 
Study 1: HP d0–35 d35 d35  d0-21*  
 
[151] 
Hop β-
acids†(360 
mg/kg)  
441a 337 214 NA 1.51 
Colistin 
sulfate (40 
mg/kg) 
425a 366 230 NA 1.51 
Control 387b 349 219 NA 1.72 
Study 2: HP d21 d21 d21 d21   
 
 
 
[152] 
Two 
Macrocephala 
Flavored 
Powder (3000 
mg/kg)  
NA 121 66.30 7.93a NA 
Colistin 
sulfate (300 
mg/kg) 
NA 107 57.63 6.48a NA 
Control NA 120.49 64.75 6.63 NA 
Study 3: HP d1-21 d21 d21 Ileum 
d21†† 
d1-7*  
 
 
[79] 
Recombinant 
plectasin (Ple) 
(60 mg/kg)  
311.43a 227.69 95.53 6.61 10.48 
Colistin 
sulfate (60 
mg/kg) 
333.57a 195.57 88.48 5.86 8.57 
Control 193.10b 160.45 105.82 6.29 36.19 
Study 4: HP d0-14    d0-14  
 
 
[81] 
Medium-
chain 
triglyceride 
(MCT) (3000 
mg/kg)  
141.2 NA NA NA 0.91 
Colistin 
sulfate (40 
mg/kg) 
142.2 NA NA NA 0.91 
Control 130.7 NA NA NA 1.01 
Study 5: HP d28-56 d42 d42  d28-56**  
 
 
[157] 
Freshwater 
microalgae 
Chlorella 
395 435 278 NA 24b 
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vulgaris 
(1000 mg/kg) 
Colistin 
sulfate (20 
mg/kg) 
400 440 283 NA 34a 
Control 393 415 299 NA 36a 
Study 6: CP  † d1 post 
challenge 
† d1 post 
challenge 
   
 
 
[158] 
Live yeast 
(5×1010 
CFU/kg)  
NA 322 246 NA NA 
Colistin 
sulfate (1000 
mg/kg) 
NA 334 236 NA NA 
Control NA 294 199 NA NA 
HP: Healthy pigs. CP: Challenged pigs. † Jejunum. NA: not available.* Diarrhea occurrence was 
calculated as the proportion of days in which pigs showed clinical signs of diarrhea.** Number of 
pig days with diarrhoea score ≥2.  a. b : values within a row with different superscripts differ 
significantly at P < 0.05. ††: log (copies/g). Live yeast: Saccharomyces cerevisiae. 
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Figure  
 
 
Fig. 1 The multifactorial genesis of post weaning diarrhea (PWD) in pigs involves 
interaction between predisposing, contributing and determining factors. PW: Post weaning. 
ETEC: Enterotoxigenic Escherichia coli. EPEC: Enteropathogenic Escherichia coli. 
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Fig. 2 Schematic representation of the steps involved in the pathogenesis of post weaning 
diarrhea in pigs.  
 
	 61	
 
Fig. 3 Illustrative interventions for the management of post-weaning diarrhea in pig farms 
(Inspired from [159]). *	Vaccination just prior to or at weaning.  
 
